Bone resorption inhibitors
Bone resorption inhibitors are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. They are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget
 |
 |
FDA Consumer Updates
Recently Approved
- Nymalize Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following...
- Breo Ellipta Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid / long-acting beta2 agonist...
- Liptruzet Liptruzet (atorvastatin and ezetimibe) is a statin (HMG-CoA reductase inhibitor) and cholesterol absorption...
- Procysbi Procysbi (cysteamine bitartrate) is a cystine depleting agent indicated for the treatment of nephropathic...
- Kcentra
Get Updates by Email
Email me:
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here